Dados B3 › AALR3 × HAPV3 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | AALR3 | HAPV3 | year |
|---|---|---|---|
| ROE | -335.8% | -0.3% | 2025 |
| ROIC | -74.6%! | 1.8%! | 2025 |
| ROA | -58.8% | -0.2% | 2025 |
| Gross margin | 20.8% | 11.8% | 2025 |
| EBIT margin | -90.3% | 4.6% | 2025 |
| Net margin | -118.9% | -0.5% | 2025 |
| Net debt/EBITDA | 2.82x | 1.62x | 2024 |
| Current ratio | 0.28x | 1.90x | 2025 |
| Revenue growth (1y) | -2.0% | 9.2% | 2025 |
| Revenue growth (5y CAGR) | 4.4% | 29.8% | 2025 |
| Piotroski F-Score | 4/9 | 6/9 | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | AALR3 | HAPV3 | year |
|---|---|---|---|
| P/E | -0.36x | -27.50x | 2025 |
| P/B | — | 0.08x | 2025 |
| EV/EBITDA | — | 2.95x | 2025 |
| FCF yield | 25.2% | 26.2% | 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:08 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it